Thomas Schwaab, MD, PhD

PrintE-mail
Assistant Professor, Department of Urology
Assistant Professor, Department of Immunology
Roswell Park Cancer Institute

Profile

Areas of Expertise: 
Bladder cancer
Kidney cancer
Prostate cancer
Testicular cancer
Partial nephrectomy
Robotic kidney surgery
Retroperitoneal surgery
IVC surgery advanced in kidney cancers

Research

Research Interests: 
Role for partial nephrectomy
Immunotherapy for bladder, prostate and kidney cancers
Robotic simulation

Background Information

Education and Training: 
MD - Medizinische Hochscule Hannover, Hannover, Germany
PhD - Medizinische Hochscule Hannover, Hannover, Germany
Residency: 
Klinikum Lippe-Detmold, Detmold, Germany
Dartmouth-Hitchcock Medical Center, Lebanon, NH
Board Certification: 
Urology, American Board of Urology
Fellowships: 
Tumor Immunotherapy Program, Dartmouth College, Hanover, NH

Publications

Publications: 
  • Hellenthal NJ, Mansour AM, Hayn MH, Schwaab T. Renal cell carcinoma in octogenarians: nephron sparing surgery should remain the standard of care. Journal of urology 2011; 185(2):415-420
  • Kowalik T, Schwaab T. Editorial comment for san francisco et Al. Journal of endourology 2011; 25(2):308-309
  • Hayn MH, Schwaab T, Underwood W, Kim HL. RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy. BJU international 2011; 108(6):876-881
  • O'Malley RL, Brewer KA, Hayn MH, Kim HL, Underwood W 3rd, Pili R, Schwaab T. Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible? . Urology 2011; 78(3):595-600
  • Schwaab T, Ernstoff MS. Therapeutic vaccines in renal cell carcinoma. Therapy 2011; 4(8):369-377
  • Schwaab T, Pili R. Provenge: combating prostate cancer with a vengeance? . Expert review of vaccines 2011; 10(8):1113-1114
  • O'Malley RL, Kowalik T, Hayn MH, Collins TB, Kim HL, Schwaab T. Cost comparison of laparoscopic partial nephrectomy and robot-assisted laparoscopic partial nephrectomy : 2011 Genitourinary Cancers Symposium. Journal of clinical oncology 2011; 29(7 Suppl.):402
  • O'Malley RL, Kowalik T, Hayn MH, Collins TB, Underwood W, Kim HL, Schwaab T. Utilization of partial nephrectomy at a cancer center in the modern era : 2011 Genitourinary Cancers Symposium. Journal of clinical oncology 2011; 29(7 Suppl.):370
  • Schwaab M, Hansen S, Gurr A, Schwaab T, Minovi A, Sudhoff H, Dazert S. Protein isolation from ear wax made easy. European archives of oto-rhino-laryngology 2009; 266(11):1699-1702
  • Schwaab T, Schwarzer A, Wolf B, Crocenzi TS, Seigne JD, Crosby NA, Cole BF, Fisher JL, Uhlenhake JC, Mellinger D, Foster C, Szczepiorkowski ZM, Webber SM, Schned AR, Harris RD, Barth Jr RJ, Heaney JA, Noelle RJ, Ernstoff MS. Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients. Clinical cancer research 2009; 15(15):4986-4992
  • Brewer K, O'Malley RL, Hayn M, Safwat MW, Kim H, Underwood W 3rd, Schwaab T. Perioperative and renal function outcomes of minimally invasive partial nephrectomy for t(1b) and t(2a) kidney tumors. Journal of endourology 2012; 26(3):244-248
  • O'Malley RL, Hayn MH, Hellenthal NJ, Kim HL, Underwood W 3rd, Schwaab T. Safety and outcomes of surgical treatment of renal cell carcinoma in the elderly. Canadian journal of urology 2012; 19(1):6111-6117
  • Kossoff E, Batty N, Ceacareanu AC, Attwood K, Miller D, Rabey J, Lee C, Ahmad A, Ebos JM, Schwaab T, George S, Pili R. Evaluation of parameters for treatment duration of sunitinib in metastatic renal cell carcinoma. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e15042
  • Narayanan R, O'Malley RL, Brewer K, Hayn MH, Mehedint D, Safwat MW, Kim HL, Underwood W, Schwaab T. Partial versus radical nephrectomy in the elderly: A surgical conundrum. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e15046
  • Safwat MW, O'Malley R, Kristopher A, Mehedint D, Narayanan R, Schwaab T. Oncologic kidney surgery in obese patients. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e15039
  • Narayanan R, O'Malley RL, Mehedint D, Schwaab T. Upper pole kidney tumors: Open or laparoscopic partial nephrectomy? : 2012 Genitourinary Cancers Symposium. Journal of clinical oncology 2012; 30(5 Suppl.):Abstract #429
  • O'Malley RL, Hayn MH, Wilding G, Schwaab T. Population-based analysis of cancer control of partial nephrectomy for high-risk localized renal cell carcinoma : 2012 Genitourinary Cancers Symposium. Journal of clinical oncology 2012; 30(5 Suppl.):Abstract #385
  • Poch MA, Mehedint D, Curtis A, Attwood K, Wilding GE, Ondracek RP, Underwood W, Schwaab T, Guru K, Mohler J, Heemers H. Association of calcium channel blocker use with prostate cancer aggressiveness, progression-free survival, and overall survival : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e15204

Cancer Can't Win

More patients are being diagnosed with cancer every day.

Here at Roswell Park Cancer Institute, we must continue to do what we do best – to understand, prevent and cure cancer. Because if we don’t, cancer wins. And Cancer Can’t Win.

  • With more than 3,000 scientific, academic and medical minds – Cancer Can’t Win.
  • When we are leading an advanced genetic program and creating next generation cancer vaccines to prevent it – Cancer Can’t Win.
  • When we are starting 13 new companies to advance our discoveries and share them with the world – Cancer Can’t Win.

Learn more about why Cancer Can’t Win

close